BAXTER INTERNATIONAL INC. (BAX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 3.59B USD | Liabilities, Current |
| Cash and equivalents | 2.15B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.86B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 2.26B USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.59B | $2.15B | (m) | $1.86B | $2.26B | (m) |
| 2026-03-31 | (m) | $3.69B | $2.02B | (m) | $1.70B | $2.32B | (m) |
| 2025-12-31 | (m) | $2.97B | $1.97B | (m) | $1.86B | $2.23B | (m) |
| 2025-09-30 | (m) | $3.77B | $1.73B | (m) | $1.78B | $2.46B | (m) |
| 2025-06-30 | (m) | $2.94B | $1.69B | (m) | $1.77B | $2.38B | (m) |
| 2025-03-31 | (m) | $3.48B | $2.29B | (m) | $1.65B | $2.17B | (m) |
| 2024-12-31 | (m) | $6.51B | $1.76B | (m) | $1.68B | $2.05B | (m) |
| 2024-09-30 | (m) | $6.20B | $1.42B | (m) | $1.73B | $2.10B | (m) |
| 2024-06-30 | (m) | $6.13B | $2.10B | (m) | $2.64B | $2.98B | (m) |
| 2024-03-31 | (m) | $6.37B | $3.03B | (m) | $2.52B | $2.99B | (m) |
| 2023-12-31 | (m) | $6.50B | $3.19B | (m) | $2.69B | $2.82B | (m) |
| 2023-09-30 | (m) | $6.21B | $5.79B | (m) | $2.51B | $2.87B | (m) |
| 2023-06-30 | (m) | $5.76B | $1.72B | (m) | $2.50B | $2.90B | (m) |
| 2023-03-31 | (m) | $4.76B | $1.67B | (m) | $2.55B | $2.92B | (m) |
| 2022-12-31 | (m) | $4.75B | $1.72B | (m) | $2.66B | $2.72B | (m) |
| 2022-09-30 | (m) | $3.71B | $1.60B | (m) | $2.56B | $2.67B | (m) |
| 2022-06-30 | (m) | $3.92B | $1.85B | (m) | (m) | $2.66B | (m) |
| 2022-03-31 | (m) | $3.89B | $2.29B | (m) | (m) | $2.55B | (m) |
| 2021-12-31 | (m) | $4.24B | $2.95B | (m) | $2.63B | $2.45B | (m) |
| 2021-09-30 | (m) | $3.44B | $3.26B | (m) | (m) | $2.02B | (m) |
| 2021-06-30 | (m) | $3.34B | $3.14B | (m) | (m) | $2.06B | (m) |
| 2021-03-31 | (m) | $3.19B | $3.18B | (m) | (m) | $2.02B | (m) |
| 2020-12-31 | (m) | $3.33B | $3.73B | (m) | $2.08B | $1.92B | (m) |
| 2020-09-30 | (m) | $3.42B | $4.36B | (m) | (m) | $1.99B | (m) |
| 2020-06-30 | (m) | $2.88B | $4.08B | (m) | (m) | $1.91B | (m) |
| 2020-03-31 | (m) | $3.04B | $4.11B | (m) | (m) | $1.69B | (m) |
| 2019-12-31 | (m) | $3.23B | $3.33B | (m) | $1.90B | $1.65B | (m) |
| 2019-09-30 | (m) | $2.61B | $3.01B | (m) | (m) | $1.72B | (m) |
| 2019-06-30 | (m) | $2.60B | $2.92B | (m) | (m) | $1.76B | (m) |
| 2019-03-31 | (m) | $3.33B | $1.91B | (m) | (m) | $1.75B | (m) |
| 2018-12-31 | (m) | $2.84B | $1.83B | (m) | (m) | $1.65B | (m) |
| 2018-09-30 | (m) | $2.70B | $2.86B | (m) | (m) | $1.72B | (m) |
| 2018-06-30 | (m) | $2.63B | $2.86B | (m) | (m) | $1.62B | (m) |
| 2018-03-31 | (m) | $2.64B | $2.95B | (m) | (m) | $1.58B | (m) |
| 2017-12-31 | (m) | $2.82B | $3.39B | (m) | (m) | $1.48B | (m) |
| 2017-09-30 | (m) | $2.66B | $3.52B | (m) | (m) | $1.55B | (m) |
| 2017-06-30 | (m) | $2.56B | $3.82B | (m) | (m) | $1.52B | (m) |
| 2017-03-31 | (m) | $2.44B | $2.86B | (m) | (m) | $1.48B | (m) |
| 2016-12-31 | (m) | $2.74B | $2.80B | (m) | (m) | $1.43B | (m) |
| 2016-09-30 | (m) | $2.61B | $2.60B | (m) | (m) | $1.57B | (m) |
| 2016-06-30 | (m) | $3.72B | $2.63B | (m) | (m) | $1.59B | (m) |
| 2016-03-31 | (m) | $3.82B | $2.21B | (m) | (m) | $1.68B | (m) |
| 2015-12-31 | (m) | $5.75B | $2.21B | (m) | (m) | $1.60B | (m) |
| 2015-09-30 | (m) | $5.98B | $1.97B | (m) | (m) | $1.70B | (m) |
| 2015-06-30 | (m) | $6.31B | $6.68B | (m) | (m) | $3.84B | (m) |
| 2015-03-31 | (m) | $6.07B | $2.53B | (m) | (m) | $3.50B | (m) |
| 2014-12-31 | (m) | $6.04B | $2.92B | (m) | (m) | $3.56B | (m) |
| 2014-09-30 | (m) | $5.99B | $2.08B | (m) | (m) | $3.70B | (m) |
| 2014-06-30 | (m) | $5.79B | $1.87B | (m) | (m) | $3.84B | (m) |
| 2014-03-31 | (m) | $5.64B | $2.05B | (m) | (m) | $3.75B | (m) |
| 2013-12-31 | (m) | $5.91B | $2.73B | (m) | (m) | $3.50B | (m) |
| 2013-09-30 | (m) | $5.00B | $2.38B | (m) | (m) | $3.58B | (m) |
| 2013-06-30 | (m) | $4.52B | $5.99B | (m) | (m) | $3.07B | (m) |
| 2013-03-31 | (m) | $4.78B | $2.69B | (m) | (m) | $2.96B | (m) |
| 2012-12-31 | (m) | $4.76B | $3.27B | (m) | (m) | $2.80B | (m) |
| 2012-09-30 | (m) | $4.46B | $3.19B | (m) | (m) | $2.83B | (m) |
| 2012-06-30 | (m) | $4.87B | $2.35B | (m) | (m) | $2.73B | (m) |
| 2012-03-31 | (m) | $4.86B | $2.27B | (m) | (m) | $2.74B | (m) |
| 2011-12-31 | (m) | $4.86B | $2.90B | (m) | (m) | $2.63B | (m) |
| 2011-09-30 | (m) | $4.17B | $2.34B | (m) | (m) | $2.62B | (m) |
| 2011-06-30 | (m) | $4.03B | $2.02B | (m) | (m) | $2.65B | (m) |
| 2011-03-31 | (m) | $3.89B | $2.17B | (m) | (m) | $2.52B | (m) |
| 2010-12-31 | (m) | $4.04B | $2.69B | (m) | (m) | $2.37B | (m) |
| 2010-09-30 | (m) | $4.20B | $2.79B | (m) | (m) | $2.50B | (m) |
| 2010-06-30 | (m) | $4.08B | $2.30B | (m) | (m) | $2.38B | (m) |
| 2010-03-31 | (m) | $4.28B | $2.67B | (m) | (m) | $2.48B | (m) |
| 2009-12-31 | (m) | $4.46B | $2.79B | (m) | (m) | $2.56B | (m) |
| 2009-09-30 | (m) | $3.47B | $2.57B | (m) | (m) | $2.63B | (m) |
| 2009-06-30 | (m) | $3.40B | $1.80B | (m) | (m) | $2.50B | (m) |
| 2009-03-31 | (m) | (m) | $1.70B | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $3.63B | $2.13B | (m) | (m) | $2.36B | (m) |
| 2008-09-30 | (m) | (m) | $2.19B | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | $2.15B | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $2.54B | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | $2.48B | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |